Skip to main content
Premium Trial:

Request an Annual Quote

Gene Logic, Genstruct Partner on Toxicology Screening

NEW YORK (GenomeWeb News) — Gene Logic and Genstruct will partner in an effort to market screening technologies that their pharmaceutical clients could use to test the potential toxicity of various compounds, the firms said today in a joint statement.

Under the collaboration, Gene Logic will offer its toxicology databases and data on specific compounds for preclinical and clinical research to pharmaceutical, biotechnology, consumer products and other industries, the company said. Genstruct will apply its Causal Network Modeling platform to create network models that capture toxicity potential of compounds.

The companies also will conduct co-marketing initiatives for each others' products. They also said that they intend to collaborate on personalized oncology therapy.

Genstruct President and CEO Keith Elliston, who formerly served as CSO of Gene Logic, said in a statement that the partners plan to generate gene expression data from patient tumors, which will be analyzed using Genstruct's systems biology platform. The information derived from the analysis could be used by physicians to devise optimal therapy for each patient, he said.

The Scan

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.

Team Presents Cattle Genotype-Tissue Expression Atlas

Using RNA sequences representing thousands of cattle samples, researchers looked at relationships between cattle genotype and tissue expression in Nature Genetics.

Researchers Map Recombination in Khoe-San Population

With whole-genome sequences for dozens of individuals from the Nama population, researchers saw in Genome Biology fine-scale recombination patterns that clustered outside of other populations.

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.